Cross-Sector entity
Of the tracked stories, 2 of 2 also mention ClaimsFiler, the most common co-covered peer. legal-tech accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 2 original sources each. Kyndryl Holdings, Inc. appears in 2 tracked Cross-Sector stories from February 19, 2026.
2 verified stories tracked
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention ClaimsFiler, the most common co-covered peer. legal-tech accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 2 original sources each. Kyndryl Holdings, Inc. appears in 2 tracked Cross-Sector stories from February 19, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kyndryl Holdings, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Anticipated Amended Complaint
Expected filing of detailed allegations following the appointment of lead plaintiffs.
Lead Plaintiff Deadline
Final date for eligible investors to file applications to lead the class action lawsuits.
Judicial Review
Courts expected to begin selecting lead plaintiffs and lead counsel for the consolidated cases.
Shareholder Alerts Issued
ClaimsFiler releases formal reminders for KD and QURE investors regarding legal deadlines.
Legal Alert Issued
ClaimsFiler reminds shareholders of upcoming deadlines for lead plaintiff applications.
Investors in uniQure N.V. and Kyndryl Holdings have until April 13, 2026, to file as lead plaintiffs in securities class action lawsuits following significant stock losses. The litigation highlights increasing regulatory and disclosure pressures on biotech firms specializing in complex gene therapies.
ClaimsFiler has issued a critical reminder for investors in Kyndryl Holdings and uniQure N.V. regarding upcoming lead plaintiff deadlines in ongoing securities class action litigation. Shareholders with losses exceeding $100,000 have until April 13, 2026, to seek lead plaintiff status in cases alleging potential violations of federal securities laws.
Source: Postregister · Hastingstribune
